Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    XBiotech Inc.

    NASDAQ: XBIT · Real-Time Price · USD
    3.18
    0.21 (7.07%)
    At close: Jul 01, 2025, 3:59 PM
    3.17
    -0.31%
    After-hours: Jul 01, 2025, 04:04 PM EDT

    XBiotech Statistics

    Share Statistics

    XBiotech has 30.49M shares outstanding. The number of shares has increased by 0.08% in one year.

    Shares Outstanding

    n/a
    		 30.49M

    Shares Change (YoY)

    n/a
    		 0.08%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 15.48%

    Shares Floating

    n/a
    		 19.5M

    Failed to Deliver (FTD) Shares

    n/a
    		 446

    FTD / Avg. Volume

    n/a
    		 0.46%

    Short Selling Information

    The latest short interest is 995.99K, so 3.27% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 995.99K

    Short % of Shares Out

    n/a
    		 3.27%

    Short % of Float

    n/a
    		 5.03%

    Short Ratio (days to cover)

    n/a
    		 18.06

    Valuation Ratios

    The PE ratio is -3.12 and the forward PE ratio is null. XBiotech's PEG ratio is -0.06.

    PE Ratio

    n/a
    		 -3.12

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.66

    P/FCF Ratio

    n/a
    		 -3.73

    PEG Ratio

    n/a
    		 -0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for XBiotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.56, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 11.56

    Quick Ratio

    n/a
    		 11.56

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.28

    Debt / FCF

    n/a
    		 -0.32

    Interest Coverage

    n/a
    		 -52.63

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-418,815.22

    Employee Count

    n/a
    		 92

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -32K

    Effective Tax Rate

    n/a
    		 0.08%

    Stock Price Statistics

    The stock price has increased by -46.31% in the last 52 weeks. The beta is 0.97, so XBiotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.97

    52-Week Price Change

    n/a
    		 -46.31%

    50-Day Moving Average

    n/a
    		 2.86

    200-Day Moving Average

    n/a
    		 4.61

    Relative Strength Index (RSI)

    n/a
    		 57.71

    Average Volume (20 Days)

    n/a
    		 97,756

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -42.47M

    Net Income

    n/a
    		 -38.53M

    EBITDA

    n/a
    		 -36.01M

    EBIT

    n/a
    		 -39.37M

    Earnings Per Share (EPS)

    n/a
    		 -1.26
    Full Income Statement

    Balance Sheet

    The company has 172.68M in cash and 10.25M in debt, giving a net cash position of 162.43M.

    Cash & Cash Equivalents

    n/a
    		 172.68M

    Total Debt

    n/a
    		 10.25M

    Net Cash

    n/a
    		 162.43M

    Retained Earnings

    n/a
    		 -90.84M

    Total Assets

    n/a
    		 181.86M

    Working Capital

    n/a
    		 152.28M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -30.96M and capital expenditures -1.3M, giving a free cash flow of -32.27M.

    Operating Cash Flow

    n/a
    		 -30.96M

    Capital Expenditures

    n/a
    		 -1.3M

    Free Cash Flow

    n/a
    		 -32.27M

    FCF Per Share

    n/a
    		 -1.06
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    XBIT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for XBIT.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 6.75

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist